Lose Weight —and Support Your Heart and Kidneys—with Jardiance® (empagliflozin)
Jardiance® (empagliflozin) is a medication that helps lower blood sugar in type 2 diabetes and reduces the risk of heart-related death. It also supports heart failure treatment by helping the body remove excess sugar through urine.
- Balances blood sugar
- Same active ingredient in Wegovy® and Ozempic®.
- Personalized weight loss plans from meto’s licensed experts
Everything you need to know about Injectable compounded Jardiance® (empagliflozin)
What is Jardiance
Jardiance is an oral sodium–glucose co-transporter-2 (SGLT-2) inhibitor prescribed once daily. By prompting the kidneys to pass excess glucose (and calories) into the urine, it helps adults with type 2 diabetes improve blood-sugar control, lowers cardiovascular and renal risk, and delivers a modest but steady reduction in body weight when it is paired with nutrition changes and regular activity. In clinical programmes most users lost roughly two-to-three percent of their starting weight over six-to-twelve months, and nearly one in six achieved at least a five-percent loss at one year
Is Jardiance safe and effective for weight loss?
Placebo-controlled studies report average reductions of 2 %–3.2 % of baseline body weight after 24 – 52 weeks; fat rather than muscle accounts for most of the change.
The weight benefit is modest but durable and comes alongside proven cardiometabolic protection, making the medicine a useful adjunct for patients seeking gradual loss rather than the larger drops seen with appetite-regulating injectables.
How does Jardiance work
SGLT-2 transporters in the first segment of the renal tubule normally recapture most of the sugar that the kidneys filter each day. Empagliflozin selectively blocks these pumps, so glucose and a small amount of sodium remain in the urine and leave the body.
That mechanism produces a daily calorie loss of roughly 200–300 kcal, a mild water-and-salt diuresis that can lower blood pressure, and downstream improvements in cardiac and renal workload.
April 2025 retail prices in U.S. pharmacies range from about $620 to $700 for a 30-day supply, but GoodRx coupons can lower the cash price to roughly $623. Commercial-insurance copays often fall once the manufacturer’s savings card is applied, and a patient-assistance programme is available for the uninsured.
